Damora Therapeutics DMRA
NASDAQ DMRA
$24.15 +0.08 (+0.33%)
At close: Nov 10, 2026 · 4:00 PM EST

Damora Therapeutics (DMRA) Other Operating Expenses (2019 - 2025)

Updated

Damora Therapeutics (DMRA) posted Other Operating Expenses of $174.31 million for Q4 2025, compared with $4.4 million a year earlier.

Analysis

Damora Therapeutics (DMRA) Other Operating Expenses (2019 - 2025) Analysis & Trends

  • In prior years, Damora Therapeutics' Other Operating Expenses was $4.4 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Damora Therapeutics 1.49 Bn -364.52 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 174.31 Mn
Dec 31, 2024 4.40 Mn
Dec 31, 2019 16.79 Mn
API Access

Damora Therapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=DMRA&period=max&api_key=YOUR_API_KEY